article thumbnail

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

If there is a quick agreement with an expectation for changes to be implemented around 2029, Olteanu says crucial investment decisions can be made while considering the Pharma Package as investment remains one of the key challenges holding Europe back from its dreams of global competitiveness.

article thumbnail

Big pharma braces for revenue headwinds as patent expiries loom

Pharmaceutical Technology

Other drugs are set to face competition too, with both MSD’s Keytruda (pembrolizumab) and Johnson & Johnson’s (J&J) Darzalex/Faspro (daratumumab and hyaluronidase-fihj) losing US exclusivity by 2029, representing a particular headwind in oncology. How will RFK Jr’s American dream for vaccines play out?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Organon drug for endometriosis falls short in mid-stage study

BioPharma Dive

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Dive Brief Organon drug for endometriosis falls short in mid-stage study Company executives had seen the drug as a potential multi-billion dollar opportunity in women’s health.

article thumbnail

AbbVie buys $2.1bn Capstan, adding new in vivo CAR-T to pipeline

Pharmaceutical Technology

According to William Blair, forecast revenue rate from 2024 to 2029 growth rate for AbbVie trails only Eli Lilly and Sanofi, representing an “attractive opportunity” for long-term investors. How will RFK Jr’s American dream for vaccines play out?

article thumbnail

Vetter breaks ground on $285m US clinical manufacturing site

Pharmaceutical Technology

The facility will be complete and ready for media fill by late 2029, with plans to move Vetter’s existing clinical operations in Skokie. How will RFK Jr’s American dream for vaccines play out? The planned 160,000ft² facility will focus on aseptic production and includes areas for material preparation and compounding.

article thumbnail

WHO endorses Gilead’s Yeztugo for HIV prevention

Pharmaceutical Technology

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out?

article thumbnail

CHMP rejects Elevidys in latest setback for Sarepta

Pharmaceutical Technology

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? According to GlobalData, the CGT market was estimated to be $5.88bn in 2023 and is projected to reach $80bn by 2029. GlobalData is the parent company of Clinical Trials Arena.